BUSINESS REGISTRATION NUMBER
BRN 65012595

Live

RELI PHARMED INTERNATIONAL LIMITED

睿麗醫藥國際有限公司

Registry Verified: 2026-11-15

Jurisdiction: Hong Kong, China

RELI PHARMED INTERNATIONAL LIMITED (睿麗醫藥國際有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 2262844, and Business Registration Number (BRN) is 65012595. Incorporated on 2015-07-14, the entity has maintained continuous statutory operations for 11 years and 4 months, currently holding an active legal status of Live. The registered office is situated at ROOM 505, 5/F, BEVERLEY COMMERCIAL CENTRE, 87-105 CHATHAM ROAD SOUTH, TSIM SHA TSUI, KOWLOON, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), its annual return filing window falls between Jul 14 – Aug 25 (within 42 days after its incorporation anniversary), with the latest Annual Return (Form NAR1) officially filed on 2026-07-21; a total of 25 statutory filings (spanning 2015–2026, latest filed on 2026-07-21) are indexed in the registry, comprising 11 Annual Return(s) (NAR1), 4 officer/secretary change notice(s) (ND2A), 4 registered office change(s) (NR1).

I. Statutory Registry Records & Hong Kong Virtual Office Background Verification

Official Chinese Name	睿麗醫藥國際有限公司	Official English Name	RELI PHARMED INTERNATIONAL LIMITED
Company Reg No. (CRN)	2262844	Business Reg No. (BRN / UBI)	65012595 HK Unique Business ID · US IRS Form W-8BEN-E Foreign TIN
Incorporation Date	2015-07-14	Company Category	Private company limited by shares
Current Legal Status	Live	Statutory Filing Cycle	2027-07-14(2026 Return Filed) 42d NAR1 Window: Jul 14 – Aug 25 · Latest NAR1: 2026-07-21

Registered Office Address	ROOM 505, 5/F, BEVERLEY COMMERCIAL CENTRE, 87-105 CHATHAM ROAD SOUTH, TSIM SHA TSUI, KOWLOON, HONG KONGBeverley Commercial Centre · Tsim Sha Tsui · 17,871 Co-Located Entities →
Significant Controllers (SCR)	Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

#	Filing Date	Document No.	Document Name	Pages	Tariff
1	2026-07-21	23102565638	NAR1 Annual Return (2026) (English)Latest Shareholders & Directors	9	HK$ 28
2	2025-07-18	23302417586	NAR1 Annual Return (2025) (English)	9	HK$ 28
3	2024-07-15	22502411113	NAR1 Annual Return (2024) (English)	9	HK$ 28
4	2023-12-27	SH000660106	BRN_REF Reference Document for Business Registration Number as UBI	1	HK$ 30
5	2023-07-18	23402112849	NAR1 Annual Return (2023) (English)	8	HK$ 28
6	2022-07-18	23302000313	NAR1 Annual Return (2022) (English)	8	HK$ 28
7	2021-07-16	22702365226	NAR1 Annual Return (2021) (English)	8	HK$ 28
8	2020-08-03	22301965867	NR1 Notice of Change of Address of Registered Office (English)	1	HK$ 20
9	2020-07-14	22501989939	NAR1 Annual Return (2020) (Chinese)	8	HK$ 28
10	2020-07-14	22401918994	ND2A Notice of Change of Company Secretary and Director (Chinese)	3	HK$ 20

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Corporate Statutory Dossier & Legal Status FAQ

Is RELI PHARMED INTERNATIONAL LIMITED currently active and in good standing with the Hong Kong Companies Registry?

Yes. RELI PHARMED INTERNATIONAL LIMITED is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2015-07-14 (operating for 11 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: November 2026).

What is the Hong Kong Foreign TIN (IRS Form W-8BEN-E) and BRN/CRN for RELI PHARMED INTERNATIONAL LIMITED?

The statutory primary identifiers for RELI PHARMED INTERNATIONAL LIMITED are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [65012595] (effective from 27 December 2023 under Cap. 310, this 8-digit number serves as the unified corporate identifier and the official Foreign TIN for US IRS Form W-8BEN-E, Line 9b); 2. Company Registration Number (CRN): [2262844] (Cap. 622 incorporation archive number; do not enter the 7-digit CRN as the tax ID). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

How can I check the current board of directors, authorized signatories, and shareholding structure of RELI PHARMED INTERNATIONAL LIMITED?

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

What statutory corporate documents are officially filed and accessible for RELI PHARMED INTERNATIONAL LIMITED?

Yes. Statutory indexing confirms that RELI PHARMED INTERNATIONAL LIMITED has accumulated 25 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2026-07-21: Form NAR1 - Annual Return (2026) (English)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

Is RELI PHARMED INTERNATIONAL LIMITED's Hong Kong registered office address confirmed on official registry records?

The statutory registered office of RELI PHARMED INTERNATIONAL LIMITED on official record is situated at: [ROOM 505, 5/F, BEVERLEY COMMERCIAL CENTRE, 87-105 CHATHAM ROAD SOUTH, TSIM SHA TSUI, KOWLOON, HONG KONG]. Official registry dossiers also record 4 statutory registered office address change filing(s) (Form NR1). Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.